Form 4: Edwards Lifesciences Director Steven R. Loranger Reports Stock Grants

Director Steven R. Loranger reports receiving restricted stock units and a restricted stock award from Edwards Lifesciences on May 9, 2025.

Summary

• On May 9, 2025, Steven R. Loranger, a director of Edwards Lifesciences Corp, reported changes in beneficial ownership.
• Loranger acquired 3,528 shares of common stock through restricted stock units and 1,154 shares through a restricted stock award, both granted under the company's 2020 Nonemployee Directors Stock Incentive Program.
• Following these transactions, Loranger directly owns 65,054 shares of common stock and indirectly owns 15,000 shares through a trust.
• The restricted stock units and award are scheduled to vest 100% after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices and aligns director interests with shareholders.

Positives

• The grant of restricted stock units and awards aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The restricted stock units and award will vest after the earlier of one year from the grant date or the company's next annual meeting of stockholders.

Industry Context

This filing is a routine disclosure of stock grants to a company director, which is a common practice in publicly traded companies to incentivize and retain key personnel.

Stakeholder Impact

• The stock grants align the director's interests with those of the shareholders, potentially leading to better decision-making for the company's long-term success.

Key Dates

Keywords

Form 4, beneficial ownership, restricted stock units, restricted stock award, director, Loranger, Edwards Lifesciences, stock incentive program, vesting